In vitro diagnostics serving the fight against infectious diseases
bioMérieux
Euronext-listed company, 59% owned by Institut Mérieux
Head office in Marcy l’Etoile
(near Lyon, France)
Areas of activity
Diagnostic solutions (systems, reagents, software and services) for clinical and industrial applications
medical testing and private research or hospital laboratories, industrial quality control laboratories
15
bio-industrial production sites and 17 R&D sites
Present in
45
countries and serve more than 160 coutries
14,000
employees
Sales in 2022
€3,589 M
A GLOBAL PLAYER
IN IN VITRO DIAGNOSTICS
bioMérieux’s mission is to improve global public health through in vitro diagnostics.
The company focuses on two main areas:
- Clinical diagnostics for infectious diseases primarily, as well cardiovascular emergencies
- Industrial microbiology
bioMérieux develops, produces, and markets diagnostic systems including:
- Reagents needed to detect, identify, and quantify pathogens
- Systems to automate these tests
- Software to process and interpret laboratory tests
- Personalized services for medical testing and industrial control laboratories.
With more than 55 years of experience, bioMérieux is now a major player in the fields of in vitro diagnostics and the fight against infectious diseases. The company is a world leader in clinical microbiology and industrial microbial control. Its extensive international network make it possible to take on diseases that cut across borders and support its clients all over the world.
PIONEERING
DIAGNOSTICS
Thanks to its experience and its international R&D programs, bioMérieux can provide health professionals and industries with innovative tools to improve tomorrow’s health care:
- Point-of-care diagnostic solutions that are better integrated into treatment time
- High medical-value tests that provide quicker results and are particularly effective in the fight against multi-drug resistant bacteria
- Syndromic molecular diagnostics tests that target several bacteria, fungal infections, and parasites that could cause a particular set of symptoms (diarrhea, respiratory diseases, meningitis, etc.) in one single test
- Companion diagnostic tests for personalized medicine
- A large range of solutions to prevent and determine the source of contamination in agri-food, cosmetic and biopharmaceutical products to protect consumers’ health
- Applications for veterinary medicine, reflective of a comprehensive approach to health care that breaks down barriers between humans and animals
